We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $21.7B
1-Year Est. Return 79.24%
This Fund
S&P 500
This Quarter Est. Return
+18.01%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$23.1B
AUM Growth
-$1.32B
Cap. Flow
-$3.13B
Cap. Flow %
-13.54%
Top 10 Hldgs %
44.45%
Holding
175
New
31
Increased
22
Reduced
37
Closed
21

Top Buys

Rank Stock Value
1
EA
Electronic Arts
EA
+$1.02B
2
EXAS
Exact Sciences
EXAS
+$514M
3
CYBR
CyberArk
CYBR
+$507M
4
SNPS icon
Synopsys
SNPS
+$444M
5
AVGO icon
Broadcom
AVGO
+$319M

Top Sells

Rank Stock Value
1
ADSK icon
Autodesk
ADSK
+$528M
2
TMO icon
Thermo Fisher Scientific
TMO
+$352M
3
TRU icon
TransUnion
TRU
+$333M
4
INTU icon
Intuit
INTU
+$333M
5
K
Kellanova
K
+$323M

Sector Composition

Rank Sector Weight
1 Healthcare 41.06%
2 Technology 12.67%
3 Financials 9.75%
4 Communication Services 8.88%
5 Consumer Discretionary 4.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IONS icon
101
Ionis Pharmaceuticals
IONS
$10.5B
$380K ﹤0.01%
4,800
– –
LIVN icon
102
LivaNova
LIVN
$4.41B
$369K ﹤0.01%
6,000
– –
GMED icon
103
Globus Medical
GMED
$11.2B
$349K ﹤0.01%
4,000
– –
COR icon
104
Cencora
COR
$62.6B
$338K ﹤0.01%
1,000
– –
QURE icon
105
uniQure
QURE
$3.53B
$335K ﹤0.01%
14,000
-551,000
-98% -$21.3M
ONC
106
BeOne Medicines Ltd
ONC
$42.5B
$334K ﹤0.01%
1,100
– –
CGON icon
107
CG Oncology
CGON
$6.95B
$332K ﹤0.01%
8,000
– –
SRRK icon
108
Scholar Rock
SRRK
$7.31B
$308K ﹤0.01%
7,000
– –
IMVT icon
109
Immunovant
IMVT
$9.07B
$305K ﹤0.01%
12,000
– –
NUVL
110
DELISTED
Nuvalent
NUVL
$302K ﹤0.01%
3,000
– –
ASND icon
111
Ascendis Pharma A/S
ASND
$16.4B
$299K ﹤0.01%
1,400
– –
VCYT icon
112
Veracyte
VCYT
$3.56B
$295K ﹤0.01%
7,000
– –
GKOS icon
113
Glaukos
GKOS
$10.7B
$294K ﹤0.01%
2,600
– –
SLDPW icon
114
Solid Power Inc Warrant
SLDPW
$5.66M
$287K ﹤0.01%
405,316
– –
STOK icon
115
Stoke Therapeutics
STOK
$2.14B
$286K ﹤0.01%
+9,000
New +$271K
SBRA icon
116
Sabra Healthcare REIT
SBRA
$5.37B
$265K ﹤0.01%
14,000
– –
MMSI icon
117
Merit Medical Systems
MMSI
$5.41B
$264K ﹤0.01%
3,000
– –
GRFS
118
Grifois
GRFS
$5.38B
$262K ﹤0.01%
28,000
– –
ACLX
119
DELISTED
Arcellx
ACLX
$261K ﹤0.01%
4,000
– –
NUVB icon
120
Nuvation Bio
NUVB
$2.44B
$260K ﹤0.01%
+29,000
New +$180K
URGN icon
121
UroGen Pharma
URGN
$2.25B
$258K ﹤0.01%
11,000
– –
PACB icon
122
Pacific Biosciences
PACB
$485M
$252K ﹤0.01%
135,000
– –
GEHC icon
123
GE HealthCare
GEHC
$33.1B
$246K ﹤0.01%
3,000
– –
TWST icon
124
Twist Bioscience
TWST
$9.41B
$243K ﹤0.01%
7,650
– –
MIRM icon
125
Mirum Pharmaceuticals
MIRM
$6.01B
$237K ﹤0.01%
3,000
– –
3 4
5
6 7

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Farallon Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Farallon Capital Management held 175 positions worth $23.1B, down 5.4% from $24.4B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Farallon Capital Management withdrew a net $3.13B in Q4 2025, closing 21 positions and reducing 37 holdings. Its most notable exit was Autodesk, an estimated $528M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 33% a quarter earlier, followed by Technology and Financials.

Against the trend, Farallon Capital Management opened a new position in Electronic Arts worth $1.03B.

  • Farallon Capital Management's largest Q4 2025 buy was Electronic Arts: 5,035,000 shares worth $1.03B.
  • Farallon Capital Management added most to Boston Scientific in Q4 2025, an estimated $264M increase.
  • Farallon Capital Management's biggest Q4 2025 reduction was Thermo Fisher Scientific, cutting an estimated $352M.
  • Farallon Capital Management fully exited Autodesk in Q4 2025, selling an estimated $528M.
  • Farallon Capital Management's ten largest holdings make up 44% of its $23.1B portfolio in Q4 2025.
  • Farallon Capital Management opened 31 new positions and closed 21 in Q4 2025.
  • Farallon Capital Management's portfolio value fell 5.4% quarter-over-quarter to $23.1B.

Based on Farallon Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.